AU Patent

AU2001248701A1 — Inhibitors of histone deacetylase

Assigned to Methylgene Inc · Expires 2001-10-03 · 25y expired

What this patent protects

The invention relates to the inhibition of histone deacetylase. The invention provides compounds and methods for inhibiting histone deacetylase enzymatic activity. The invention also provides compositions and methods for treating cell proliferative diseases and conditions.

USPTO Abstract

The invention relates to the inhibition of histone deacetylase. The invention provides compounds and methods for inhibiting histone deacetylase enzymatic activity. The invention also provides compositions and methods for treating cell proliferative diseases and conditions.

Drugs covered by this patent

Patent Metadata

Patent number
AU2001248701A1
Jurisdiction
AU
Classification
—
Expires
2001-10-03
Drug substance claim
No
Drug product claim
No
Assignee
Methylgene Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.